Arrowhead Research | ARWR - EPS Earnings Per Share

Stock Price
69.33
Daily Change
0.21 0.30%
Monthly
4.43%
Yearly
248.74%
Q1 Forecast
67.19

Arrowhead Research reported $-0.11 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Dec/2025 0.04 -1.39 Feb/05 2026
FY2025Q4 Sep/2025 -0.11 -0.23 -1.36 Nov/25 2025
FY2025Q3 Jun/2025 -1.26 -0.86 -1.38 Aug/07 2025
FY2025Q2 Mar/2025 2.75 -0.11 -1.02 May/12 2025
FY2025Q1 Dec/2024 -1.39 -0.39 -1.24 Feb/10 2025




Eps Change Date
Agios Pharmaceuticals USD -1.78 0.15 Sep/2025
Alnylam Pharmaceuticals USD 2.9 2.58 Sep/2025
Arrowhead Research USD -0.11 1.15 Sep/2025
Incyte USD 2.26 0.69 Sep/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
Ligand Pharmaceuticals USD 3.09 1.49 Sep/2025
Merck USD 2.58 0.45 Sep/2025
Moderna USD -0.51 1.62 Sep/2025
Novartis USD 2.04 0.38 Sep/2025
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
TG Therapeutics USD 2.43 2.26 Sep/2025
Ultragenyx Pharmaceutical USD -1.81 0.64 Sep/2025
Vertex Pharmaceuticals USD 4.8 0.28 Sep/2025
Xencor USD -0.08 0.33 Sep/2025